Dean Erhardt, president of D2 Consulting, is scheduled to present on Wednesday, December 14th, 2016 at 8:30 a.m. ET at the Hyatt Regency in Jacksonville, Florida. Mr. Erhardt's presentation will address commercialization hurdles faced by biopharmaceutical manufacturers in driving efficient distribution and attainment of adequate product reimbursement.
About D2 Consulting
Established in 2008, D2 Consulting (D2) is recognized as the industry's leading provider of commercialization services to the life sciences industry. D2 assists emerging and established pharmaceutical, biopharmaceutical and medical device manufacturers to develop and execute strategic business initiatives, ensuring successful launch, distribution and reimbursement to support an ongoing leadership position in the marketplace.
D2's reach includes the U.S., Canada, Puerto Rico and more than 20 European markets. With more than 300 successful product launches, the Company offers strategic and tactical support services from a core team of advisors with more than 500 years of combined industry experience in more than 50 therapeutic areas. For more information on D2, please visit www.D2rx.com.
Corporate & Media Relations
D2 Consulting, LLC
Lindsay M. Rocco
Elixir Health Public Relations
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/d2-consulting-to-present-at-sebios-18th-investor-and-partnering-forum-300376282.html
SOURCE D2 Consulting